Amplitude Surgical Stock | AMPLI.PA | FR0012789667 | A14UZ2

Date	Amplitude Surgical Price
2/24/2025	3.38 undefined
2/21/2025	3.38 undefined
2/20/2025	3.38 undefined
2/19/2025	3.38 undefined
2/18/2025	3.40 undefined
2/17/2025	3.40 undefined
2/14/2025	3.42 undefined
2/13/2025	3.42 undefined
2/12/2025	3.42 undefined
2/11/2025	3.44 undefined
2/10/2025	3.42 undefined
2/7/2025	3.44 undefined
2/6/2025	3.44 undefined
2/5/2025	3.42 undefined
2/4/2025	3.50 undefined
2/3/2025	3.36 undefined
1/31/2025	3.36 undefined
1/30/2025	3.30 undefined
1/29/2025	3.22 undefined
1/28/2025	3.26 undefined

Date	Amplitude Surgical Revenue	Amplitude Surgical EBIT	Amplitude Surgical Net Income
2025e	111.22 M undefined	0 undefined	-336.14 M undefined
2024	106.02 M undefined	10 M undefined	1.53 M undefined
2023	100.2 M undefined	8.11 M undefined	39.25 M undefined
2022	87.56 M undefined	8.54 M undefined	-4.39 M undefined
2021	82.71 M undefined	-1.29 M undefined	-14.1 M undefined
2020	88.29 M undefined	-2.23 M undefined	-14.2 M undefined
2019	102.56 M undefined	-587,000 undefined	-8.99 M undefined
2018	100.34 M undefined	-128,000 undefined	-9.45 M undefined
2017	93.36 M undefined	-1.06 M undefined	-12.05 M undefined
2016	80.79 M undefined	3.46 M undefined	219,000 undefined
2015	71.09 M undefined	3.19 M undefined	-17.65 M undefined
2014	58.2 M undefined	4.5 M undefined	-2.8 M undefined
2013	50.3 M undefined	4.7 M undefined	-2.1 M undefined
2012	47.2 M undefined	4.9 M undefined	-2 M undefined
2011	0 undefined	-3.4 M undefined	-2.3 M undefined

	Revenue	EBIT	Net Income
2011	0 EUR	-3.4 M EUR	-2.3 M EUR
2012	47.2 M EUR	4.9 M EUR	-2 M EUR
2013	50.3 M EUR	4.7 M EUR	-2.1 M EUR
2014	58.2 M EUR	4.5 M EUR	-2.8 M EUR
2015	71.09 M EUR	3.19 M EUR	-17.65 M EUR
2016	80.79 M EUR	3.46 M EUR	219,000 EUR
2017	93.36 M EUR	-1.06 M EUR	-12.05 M EUR
2018	100.34 M EUR	-128,000 EUR	-9.45 M EUR
2019	102.56 M EUR	-587,000 EUR	-8.99 M EUR
2020	88.29 M EUR	-2.23 M EUR	-14.2 M EUR
2021	82.71 M EUR	-1.29 M EUR	-14.1 M EUR
2022	87.56 M EUR	8.54 M EUR	-4.39 M EUR
2023	100.2 M EUR	8.11 M EUR	39.25 M EUR
2024	106.02 M EUR	10 M EUR	1.53 M EUR
2025e	111.22 M EUR	0 EUR	-336.14 M EUR

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e
0	47	50	58	71	80	93	100	102	88	82	87	100	106	111
-	-	6.38	16.00	22.41	12.68	16.25	7.53	2.00	-13.73	-6.82	6.10	14.94	6.00	4.72
-	42.55	44.00	44.83	45.07	46.25	46.24	50.00	50.98	45.45	78.05	77.01	79.00	79.25	75.68
-3	20	22	26	32	37	43	50	52	40	64	67	79	84	0
-2	-2	-2	-2	-17	0	-12	-9	-8	-14	-14	-4	39	1	-336
-	-	-	-	750.00	-	-	-25.00	-11.11	75.00	-	-71.43	-1,075.00	-97.44	-33,700.00
27.6	27.6	27.6	31.9	46.93	46.93	46.93	46.93	47.81	47.81	47.81	48.02	48.02	48.02	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

5.9	6	3.8	3.2	56.11	32.08	41.63	29.44	19.65	36.66	30.68	21.04	37.21	29.1
10.5	11.1	12.2	15.2	16.53	20.95	16.07	12.69	12.82	8.19	10.59	10.6	11.12	14.75
3.3	3.1	4.1	5.9	6.8	7.8	7.46	7.83	5.13	5.31	6.11	7.25	7.84	5.53
14.7	17.5	23	25.3	33.17	50.72	45.3	40.12	45.56	41.53	44.52	32.9	37.96	43.3
0.5	0.6	0.5	1.2	2.81	1.69	1.21	1.31	1.3	1.37	2.54	24.87	1.33	1.97
34.9	38.3	43.6	50.8	115.41	113.24	111.67	91.38	84.46	93.06	94.43	96.65	95.46	94.65
9.7	13.2	15.8	19.4	21.19	27.31	39.13	49.49	49.59	45.7	42.21	33.53	37.28	41.46
0	0	0	100	43	411	664	690	710	703	567	468	709	465
0	0	0	0	0	0	0	0	0	0	6.91	6.34	6.96	0
0.5	1	3.3	9.6	11.51	13.67	16.48	40.41	39.26	32.19	29.24	29	31.84	37.29
78	75.5	75.5	90.4	90.88	90.87	92.93	96.11	95.97	95.82	95.67	94.72	95.63	98.8
1.7	2.2	3.1	4.6	8.04	11.77	10.09	10.12	9.95	7.73	6.96	5.09	5.11	6.59
89.9	91.9	97.7	124.1	131.66	144.02	159.29	196.82	195.47	182.14	181.55	169.15	177.52	184.6
124.8	130.2	141.3	174.9	247.07	257.27	270.96	288.21	279.92	275.21	275.98	265.8	272.98	279.26

300	300	300	300	469	469	469	469	478	478	478	480	480	480
27.3	27.3	27.3	31.6	145.51	145.51	146.69	146.69	146.68	146.68	146.68	146.68	146.68	146.68
-2.3	-4.2	-6.4	-9	-27.25	-27.83	-43.44	-51.5	-60.22	-74.25	-88.76	-92.46	-54.11	-51.06
0.1	-1	-0.7	-0.6	0.03	-0.26	-0.16	-0.06	-0.08	-0.39	0.53	-0.52	2.77	-0.27
0	0	0	0	0	0	0	0	0	0	0	0	0	0
25.4	22.4	20.5	22.3	118.76	117.88	103.55	95.59	86.86	72.52	58.92	54.18	95.81	95.82
8.8	9.1	10	16.5	16.14	23.83	16.18	15.19	12.35	11.07	11.99	11.37	15.46	15.08
3.4	3.3	3.9	4.8	6.12	5.11	6.29	9.78	9.35	10.19	8.68	6.78	7.77	9.88
4.9	7.2	13	12.7	11.45	6.5	9.71	6.43	6.39	6.6	8.7	13.96	6.87	6.72
0	0	0.2	0	0.04	0.01	0.02	0.05	0.07	0.01	0.46	0.86	0.36	1.46
2.2	24.3	4.2	7.5	14.49	5.37	2.6	4.61	6.12	18.36	8.55	10.87	10.87	13.77
19.3	43.9	31.3	41.5	48.24	40.81	34.79	36.06	34.29	46.23	38.38	43.83	41.33	46.91
70.7	53.7	79.4	100.6	68.86	75.24	116.99	115.35	114.82	123.44	137.74	127.34	95.22	102.01
1.5	0.3	0.5	0.3	0.31	0.47	0.82	1.04	1.36	1.53	2.08	1.7	1.73	2.1
8	9.9	9.8	10.2	10.91	22.62	15.22	41.07	43.96	33.1	34	34.03	31.93	32.42
80.2	63.9	89.7	111.1	80.07	98.33	133.04	157.47	160.14	158.06	173.82	163.06	128.88	136.52
99.5	107.8	121	152.6	128.31	139.15	167.83	193.52	194.43	204.29	212.21	206.89	170.2	183.43
124.9	130.2	141.5	174.9	247.07	257.03	271.38	289.12	281.29	276.81	271.13	261.07	266.02	279.26

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
-3	-2	-2	-3	-17	0	-12	-9	-9	-14	-14	-4	38
0	3	4	5	15	20	5	15	21	15	18	16	13
0	0	0	0	0	0	0	0	0	0	0	0	0
0	-4	-1	-3	-11	-15	5	0	-6	5	-3	0	6
0	0	0	0	-2	-2	3	2	2	5	2	-2	-50
0	0	0	0	0	0	0	0	0	0	2	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0
-3	-3	0	-1	-16	1	2	8	8	12	2	7	8
0	-5	-9	-13	-10	-17	-24	-13	-16	-9	-9	-12	-19
-67	-5	-8	-14	-10	-18	-32	-17	-13	-9	-9	-12	45
-67	0	0	-1	0	0	-7	-4	2	0	0	0	64
0	0	0	0	0	0	0	0	0	0	0	0	0
49	1	1	5	-33	-3	38	-4	-4	14	3	-5	-37
27	0	0	4	113	0	0	0	0	0	0	0	0
77	9	6	16	80	-8	39	-3	-4	14	0	-5	-37
0	8	5	5	0	-4	0	1	0	0	-2	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0
5	0	-2	0	52	-23	9	-12	-9	17	-5	-9	16
-3.4	-9.25	-8.97	-15.46	-27.48	-15.99	-22.2	-4.78	-8.39	2.64	-7.1	-4.16	-11.3
0	0	0	0	0	0	0	0	0	0	0	0	0

Amplitude Surgical Gross margin	Amplitude Surgical Profit margin	Amplitude Surgical EBIT margin	Amplitude Surgical Profit margin
2025e	79.36 %	0 %	-302.22 %
2024	79.36 %	9.43 %	1.44 %
2023	79.27 %	8.1 %	39.17 %
2022	77.22 %	9.76 %	-5.02 %
2021	77.77 %	-1.56 %	-17.05 %
2020	46.14 %	-2.53 %	-16.08 %
2019	51.37 %	-0.57 %	-8.77 %
2018	49.99 %	-0.13 %	-9.41 %
2017	46.61 %	-1.14 %	-12.91 %
2016	46.92 %	4.29 %	0.27 %
2015	45.33 %	4.49 %	-24.82 %
2014	46.05 %	7.73 %	-4.81 %
2013	43.94 %	9.34 %	-4.17 %
2012	43.43 %	10.38 %	-4.24 %
2011	79.36 %	0 %	0 %

	Gross margin	EBIT margin	Profit margin
2011	79.36 %	0 %	0 %
2012	43.43 %	10.38 %	-4.24 %
2013	43.94 %	9.34 %	-4.17 %
2014	46.05 %	7.73 %	-4.81 %
2015	45.33 %	4.49 %	-24.82 %
2016	46.92 %	4.29 %	0.27 %
2017	46.61 %	-1.14 %	-12.91 %
2018	49.99 %	-0.13 %	-9.41 %
2019	51.37 %	-0.57 %	-8.77 %
2020	46.14 %	-2.53 %	-16.08 %
2021	77.77 %	-1.56 %	-17.05 %
2022	77.22 %	9.76 %	-5.02 %
2023	79.27 %	8.1 %	39.17 %
2024	79.36 %	9.43 %	1.44 %
2025e	79.36 %	0 %	-302.22 %

Date	Amplitude Surgical Sales per Share	Amplitude Surgical EBIT per share	Amplitude Surgical Earnings per Share
2025e	2.32 undefined	0 undefined	-7 undefined
2024	2.21 undefined	0.21 undefined	0.03 undefined
2023	2.09 undefined	0.17 undefined	0.82 undefined
2022	1.82 undefined	0.18 undefined	-0.09 undefined
2021	1.73 undefined	-0.03 undefined	-0.29 undefined
2020	1.85 undefined	-0.05 undefined	-0.3 undefined
2019	2.15 undefined	-0.01 undefined	-0.19 undefined
2018	2.14 undefined	-0 undefined	-0.2 undefined
2017	1.99 undefined	-0.02 undefined	-0.26 undefined
2016	1.72 undefined	0.07 undefined	0 undefined
2015	1.51 undefined	0.07 undefined	-0.38 undefined
2014	1.82 undefined	0.14 undefined	-0.09 undefined
2013	1.82 undefined	0.17 undefined	-0.08 undefined
2012	1.71 undefined	0.18 undefined	-0.07 undefined
2011	0 undefined	-0.12 undefined	-0.08 undefined

	Sales per Share	EBIT per share	Earnings per Share
2011	0 EUR	-0.12 EUR	-0.08 EUR
2012	1.71 EUR	0.18 EUR	-0.07 EUR
2013	1.82 EUR	0.17 EUR	-0.08 EUR
2014	1.82 EUR	0.14 EUR	-0.09 EUR
2015	1.51 EUR	0.07 EUR	-0.38 EUR
2016	1.72 EUR	0.07 EUR	0 EUR
2017	1.99 EUR	-0.02 EUR	-0.26 EUR
2018	2.14 EUR	-0 EUR	-0.2 EUR
2019	2.15 EUR	-0.01 EUR	-0.19 EUR
2020	1.85 EUR	-0.05 EUR	-0.3 EUR
2021	1.73 EUR	-0.03 EUR	-0.29 EUR
2022	1.82 EUR	0.18 EUR	-0.09 EUR
2023	2.09 EUR	0.17 EUR	0.82 EUR
2024	2.21 EUR	0.21 EUR	0.03 EUR
2025e	2.32 EUR	0 EUR	-7 EUR

	Number of stocks
2011	27.6 M Aktien
2012	27.6 M Aktien
2013	27.6 M Aktien
2014	31.9 M Aktien
2015	46.93 M Aktien
2016	46.93 M Aktien
2017	46.93 M Aktien
2018	46.93 M Aktien
2019	47.81 M Aktien
2020	47.81 M Aktien
2021	47.81 M Aktien
2022	48.02 M Aktien
2023	48.02 M Aktien
2024	48.02 M Aktien
2025e	48.02 M Aktien

%	Name	Stocks	Date
74.96673 %	PAI Partners	35,999,024	3/28/2024
0.64911 %	Amplitude Surgical SA Management	311,702	3/28/2024
0.42420 %	Jallabert (Olivier)	203,702	6/30/2023
0.11201 %	Federal Finance Gestion	53,785	4/30/2024
0.00002 %	Caille (Daniel)	10	6/30/2023
0.00000 %	Drago (Stefano)	1	6/30/2023
0.00000 %	Pennec (Charlotte)	1	6/30/2023

What values and corporate philosophy does Amplitude Surgical represent?

Amplitude Surgical SA represents a dedication to excellence, innovation, and patient care in the field of medical technology. The company values quality and precision in designing and manufacturing orthopedic surgical instruments and implants. With a focus on improving surgical outcomes and promoting patient well-being, Amplitude Surgical SA strives to provide cutting-edge solutions for orthopedic surgeons worldwide. The corporate philosophy is centered around collaboration, research, and continuous improvement to ensure the highest standards are met. Amplitude Surgical SA's commitment to advancement in orthopedics is evident in their strong portfolio and commitment to delivering reliable, efficient, and effective products.

In which countries and regions is Amplitude Surgical primarily present?

Amplitude Surgical SA is primarily present in several countries and regions worldwide. These include France, its home country, as well as other key markets such as Germany, Spain, Italy, Belgium, the Netherlands, the United Kingdom, Switzerland, and Austria. With a strong global presence, Amplitude Surgical SA caters to the needs of patients, surgeons, and healthcare professionals across these regions.

What significant milestones has the company Amplitude Surgical achieved?

Amplitude Surgical SA has achieved significant milestones in its history. Some notable achievements include the company's successful IPO in 2017, which consolidated its position as a key player in the orthopedic surgical market. Additionally, Amplitude Surgical SA has expanded its global presence by establishing subsidiaries and distribution networks in various countries. The company has also received several regulatory approvals for its innovative medical devices, enhancing its product portfolio. These milestones highlight Amplitude Surgical SA's commitment to delivering high-quality surgical solutions and its continuous efforts to improve patient outcomes.

What is the history and background of the company Amplitude Surgical?

Amplitude Surgical SA, a leading medical device company, specializes in designing and manufacturing innovative orthopedic implants and surgical instruments for orthopedic surgeons. Established in 1997, Amplitude Surgical has grown into a global player in the field of orthopedics. The company is headquartered in Valence, France, and operates in more than 30 countries worldwide. Amplitude Surgical SA prides itself on delivering high-quality and innovative solutions for joint replacement surgeries, including prosthetic hips and knees, aiming to improve patients' quality of life. With a strong emphasis on research and development, Amplitude Surgical SA continues to expand its product portfolio and reputation across the globe.

Who are the main competitors of Amplitude Surgical in the market?

The main competitors of Amplitude Surgical SA in the market are companies such as Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, Medtronic plc, and Smith & Nephew plc.

In which industries is Amplitude Surgical primarily active?

Amplitude Surgical SA is primarily active in the medical device industry, specializing in orthopedic surgery. They focus on developing and manufacturing innovative surgical solutions for the treatment of bone and joint disorders. With a strong expertise in orthopedic implants and instruments, Amplitude Surgical SA caters to various medical specialties, including traumatology, spine surgery, and arthroplasty. Their products are designed to enhance surgical precision and efficiency, providing healthcare professionals with reliable tools to improve patient outcomes in the field of orthopedic surgery.

What is the business model of Amplitude Surgical?

The business model of Amplitude Surgical SA revolves around providing innovative and high-quality orthopedic medical devices for orthopedic surgeons worldwide. The company specializes in the design, manufacture, and distribution of surgical implants, instruments, and surgical navigation systems for joint replacement surgeries. Amplitude Surgical SA aims to improve patient outcomes and surgeon experience by offering a comprehensive range of products that ensure optimal surgical precision and efficiency. With a focus on research and development, Amplitude Surgical SA continuously adapts its product portfolio to meet the evolving needs of the orthopedic industry.

What is the P/E ratio of Amplitude Surgical 2025?

The Amplitude Surgical P/E ratio is -0.48.

What is the P/S ratio of Amplitude Surgical 2025?

The Amplitude Surgical P/S ratio is 1.46.

What is the Quality Investing of Amplitude Surgical?

The Quality Investing for Amplitude Surgical is 3/10.

What is the revenue of Amplitude Surgical 2025?

The expected Amplitude Surgical revenue is 111.22 M EUR.

How high is the profit of Amplitude Surgical 2025?

The expected Amplitude Surgical profit is -336.14 M EUR.

What is the business model of Amplitude Surgical

Amplitude Surgical SA is a leading provider of innovative medical devices for orthopedic surgery. The company offers a wide range of products for orthopedic surgeons to treat conditions such as arthritis, vascular injuries, osteoporosis, and more. Amplitude Surgical SA focuses on providing high-quality, safe, and effective products through collaboration with global experts in orthopedic surgery and conducting clinical studies. The company operates in two main areas: Total Knee Arthroplasty (TKA) and Total Hip Arthroplasty (THA). In addition to its main areas of focus, Amplitude Surgical SA also offers products for spine and shoulder surgery. The company has its headquarters in France and a global network of distribution and marketing partners. With its commitment to quality, safety, and effectiveness, as well as its wide range of products and global presence, Amplitude Surgical SA is poised for further growth.

What is the Amplitude Surgical dividend?

Amplitude Surgical pays a dividend of 0 EUR distributed over payouts per year.

How often does Amplitude Surgical pay dividends?

The dividend cannot currently be calculated for Amplitude Surgical or the company does not pay out a dividend.

What is the Amplitude Surgical ISIN?

The ISIN of Amplitude Surgical is FR0012789667.

What is the Amplitude Surgical WKN?

The WKN of Amplitude Surgical is A14UZ2.

What is the Amplitude Surgical ticker?

The ticker of Amplitude Surgical is AMPLI.PA.

How much dividend does Amplitude Surgical pay?

Over the past 12 months, Amplitude Surgical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amplitude Surgical is expected to pay a dividend of 0 EUR.

What is the dividend yield of Amplitude Surgical?

The current dividend yield of Amplitude Surgical is .

When does Amplitude Surgical pay dividends?

Amplitude Surgical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amplitude Surgical?

Amplitude Surgical paid dividends every year for the past 0 years.

What is the dividend of Amplitude Surgical?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amplitude Surgical located?

Amplitude Surgical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amplitude Surgical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amplitude Surgical from 2/26/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 2/26/2025.

When did Amplitude Surgical pay the last dividend?

The last dividend was paid out on 2/26/2025.

What was the dividend of Amplitude Surgical in the year 2024?

In the year 2024, Amplitude Surgical distributed 0 EUR as dividends.

In which currency does Amplitude Surgical pay out the dividend?

The dividends of Amplitude Surgical are distributed in EUR.

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy	90
Scope 3 - Indirect emissions within the value chain	22
Total CO₂ emissions	90
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Percentage of female employees	42
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

Stock Exchange	Amplitude Surgical Ticker
EURONEXT	AMPLI.PA
FRANKFURT	1AU.F
LONDON	0RAF.L
MUNICH	1AU.MU
NASDAQ	AMHCW
PARIS	AMPLI.PA

Amplitude Surgical Ticker	Amplitude Surgical FIGI
AMPLI:FP	BBG0099T4PM3
AMPLIEUR:EO	BBG009DX91H3
AMPLIEUR:XH	BBG009DX91L8
AMPLIEUR:XF	BBG009DX91N6
AMPLIEUR:XE	BBG009DX91Q3
AMPLIEUR:XJ	BBG009DX91R2
AMPLIEUR:XL	BBG009DX91S1
AMPLIEUR:XG	BBG009DX91T0
AMPLIEUR:XO	BBG009DX91V7
AMPLIEUR:XS	BBG009DX91Z3
AMPLIEUR:XA	BBG009DX9209
AMPLIEUR:E1	BBG009DX9218
AMPLIEUR:XT	BBG009DX9227
AMPLIEUR:XW	BBG009DX9236
AMPLIEUR:XU	BBG009DX9245
AMPLIEUR:XV	BBG009DX9263
AMPLIEUR:EU	BBG009DX9281
1AU:GR	BBG009HT44W0
1AU:GF	BBG009HT44X9
1AU:GS	BBG009HT4502
1AU:GM	BBG009HT4511
1AU:GB	BBG009HT4520
AMPLIP:L3	BBG009HT5985
AMPLIP:B3	BBG009HT5B26
AMPLIP:PO	BBG009HT5BZ0
AMPLIP:IX	BBG009J3RLL4
AMPLIP:EB	BBG009J3RM14
AMPLIEUR:XM	BBG00J9WMH42
0RAF:LN	BBG00JHW6YH0
AMPLIEUR:XX	BBG00JN8F570
AMPLIP:I2	BBG00NQ9VCV6
AMPLIP:S1	BBG00QSFC0V0
AMPLIP:BQ	BBG00RKP2WW4
AMPLIP:L1	BBG00Y7BCXB5
AMPLIP:S4	BBG00YJ7Z3J4
1AU:LA	BBG018H9DW71
1AU:LU	BBG018J31X00
AMPLIP:QX	BBG01JXCJ0X7
AMPLIP:QE	BBG01JXCJ7J8

Access the world's leading financial data and tools

Price

Price

TickerAMPLI.PA

ISINFR0012789667

WKNA14UZ2

Amplitude Surgical stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Amplitude Surgical Stock Price History

Amplitude Surgical Revenue, EBIT, Net Income FR0012789667 · A14UZ2

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Amplitude Surgical Revenue, EBIT and net profit per share

Amplitude Surgical Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Amplitude Surgical stock margins FR0012789667 · A14UZ2

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Amplitude Surgical Margin History

Amplitude Surgical Stock Sales Revenue, EBIT, Earnings per Share FR0012789667 · A14UZ2

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Amplitude Surgical Revenue, EBIT and net profit per share

Amplitude Surgical business model

Amplitude Surgical SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Amplitude Surgical Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Amplitude Surgical historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Amplitude Surgical shares outstanding FR0012789667 · A14UZ2

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

The World’s Best Investors Are On Eulerpool

Amplitude Surgical Earnings Estimates

Amplitude Surgical latest earnings and earnings surprises

Eulerpool ESG Scorecard© for the Amplitude Surgical stock

Eulerpool World ESG Rating (EESG©)

33/ 100

Ticker
AMPLI.PA

ISIN
FR0012789667

WKN
A14UZ2